iPhone | iPad
Android
Huawei
Established in 2009, the Mohamed bin Zayed (MBZ) fund has supported projects for conservation of species and subspecies across 170 countries
KT APPDOWNLOAD
Covid-19 India: Bharat Biotech cuts price of Covaxin for states
Hyderabad - Two vaccine makers slashed the prices after Central government reportedly made a request to them.
Bharat Biotech on Thursday announced that it is slashing the price of its Covid-19 vaccine Covaxin to Rs400, from Rs600 earlier, for state governments.
The announcement came a day after the Serum Institute of India (SII) cut the price of Covishield to Rs300 from Rs400 earlier.
The two vaccine makers slashed the prices after the Central government reportedly made a request to them amid the row over different pricing for the Central and state governments.
Bharat Biotech said in a statement on Thursday that it deeply concerned with the critical pandemic circumstances that India is facing at this time.
"Recognising the enormous challenges to the public healthcare system, we have made Covaxin available to state governments at a price of Rs 400 per dose," the Hyderabad-based company said.
"We wish to be transparent in our approach to pricing which was determined by internally funded product development, several operationally-intensive BSL-3 manufacturing facilities (the first of its kind in our country) and clinical trials," it added.
The company stated that for the last one year, Team Bharat Biotech has been fearlessly handling live SARS-CoV-2 virus strains, tirelessly working round-the-clock while overcoming many challenges given the uncertainty of the pandemic.
Bharat Biotech had on April 24 announced the prices of Covaxin. It fixed at Rs 1,200 as the price per dose for private hospitals. This is twice the cost fixed by the SII for Covishield.
For exports, it has priced India's first indigenous Covid vaccine at $15-$20 (Rs 1,125-1,500).
Ever since the launch of Covid vaccination programme in India, Bharat Biotech and the SII have been supplying their vaccines to the Centre at Rs150 per dose.
While Bharat Biotech is likely to continue the supplies to the Centre at the same price, the SII had hinted at revising this to Rs 400.
More news from
London and Indian cities were among the top five destinations, report shows
The book created by Emirati illustrator Mohammed Al Rais and based on a tale by Swiss author Kurt Blum, is set to capture the hearts of young readers with its delightful story of uniqueness and triumph
The idea of undergoing the procedure was 'mentally and emotionally draining', the longtime Abu Dhabi resident said, but doctors eased her worries
The ruins in the middle of Pantabangan Dam in Nueva Ecija province are a tourist draw, even as the region swelters in extreme heat
This covers traffic violations incurred until 2023
Friday's polling will be held for 88 of the total 543 seats in the lower house or Lok Sabha of Parliament with 160 million people eligible to vote
The bank’s liquidity profile remains strong as evidenced by an advances to stable resources ratio of 76% and an eligible liquid asset ratio of 16%, both comfortably above regulatory thresholds
